BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ding N, Che L, Li XL, Liu Y, Jiang LJ, Fan B, Tao JY, Chen X, Ji JF. Oncogenic potential of IDH1R132C mutant in cholangiocarcinoma development in mice. World J Gastroenterol 2016; 22(6): 2071-2080 [PMID: 26877611 DOI: 10.3748/wjg.v22.i6.2071]
URL: https://www.wjgnet.com/1007-9327/full/v22/i6/2071.htm
Number Citing Articles
1
Chiara Raggi, Maria Letizia Taddei, Colin Rae, Chiara Braconi, Fabio Marra. Metabolic reprogramming in cholangiocarcinomaJournal of Hepatology 2022; 77(3): 849 doi: 10.1016/j.jhep.2022.04.038
2
Fabiana Crispo, Michele Pietrafesa, Valentina Condelli, Francesca Maddalena, Giuseppina Bruno, Annamaria Piscazzi, Alessandro Sgambato, Franca Esposito, Matteo Landriscina. IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment—Current State and Future PerspectivesMolecules 2020; 25(16): 3754 doi: 10.3390/molecules25163754
3
Christopher J. Pirozzi, Hai Yan. The implications of IDH mutations for cancer development and therapyNature Reviews Clinical Oncology 2021; 18(10): 645 doi: 10.1038/s41571-021-00521-0
4
Takeshi Suda, Takeshi Yokoo, Tsutomu Kanefuji, Kenya Kamimura, Guisheng Zhang, Dexi Liu. Hydrodynamic Delivery: Characteristics, Applications, and Technological AdvancesPharmaceutics 2023; 15(4): 1111 doi: 10.3390/pharmaceutics15041111
5
Peeranate Vanaroj, Wanna Chaijaroenkul, Kesara Na‑Bangchang. Notch signaling in the pathogenesis, progression and identification of potential targets for cholangiocarcinoma (Review)Molecular and Clinical Oncology 2022; 16(3) doi: 10.3892/mco.2022.2499
6
Jian Wang, Zhan-guo Zhang, Ze-yang Ding, Wei Dong, Hui-fang Liang, Liang Chu, Bi-xiang Zhang, Xiao-ping Chen. IDH1 mutation correlates with a beneficial prognosis and suppresses tumor growth in IHCCJournal of Surgical Research 2018; 231: 116 doi: 10.1016/j.jss.2018.04.056
7
Yan Zhu, Lawrence N. Kwong. Insights Into the Origin of Intrahepatic Cholangiocarcinoma From Mouse ModelsHepatology 2020; 72(1): 305 doi: 10.1002/hep.31200
8
Colm J. O’Rourke, Matthias S. Matter, Chirag Nepal, Rui Caetano‐Oliveira, Phuongnga T. Ton, Valentina M. Factor, Jesper B. Andersen. Identification of a Pan‐Gamma‐Secretase Inhibitor Response Signature for Notch‐Driven CholangiocarcinomaHepatology 2020; 71(1): 196 doi: 10.1002/hep.30816
9
Tony El Jabbour, Attila Molnar, Stephen M. Lagana. Challenges in Diagnosing and Reporting CholangiocarcinomaSurgical Pathology Clinics 2023; 16(3): 599 doi: 10.1016/j.path.2023.04.012